HHS directed $1 billion toward development of vaccine for novel influenza A (H1N1)
On May 22, 2009, the U.S. Dept. of Health and Human Services (HHS) directed $1 billion toward development…
A novel influenza A (H1N1)pdm09 virus was detected first in the U.S. before spreading worldwide
On Apr. 15, 2009, a novel influenza A virus (then referred to as ‘swine origin influenza A virus’)…
Biotechnology | CDC | Diagnostics | Influenza | NIH | Therapeutics
CDC began a complex and multi-faceted response to the H1N1 pandemic
On Apr. 15, 2009, infection with the new influenza A virus (then referred to as ‘swine origin influenza…
The CDC identified the novel H1N1 influenza virus
On Apr. 15, 2009, the U.S. Centers for Disease Control and Prevention (CDC) identified the novel H1N1 influenza…
Physicians used point of care rapid immunoassay tests to provide influenza results during H1N1 pandemic
In Apr. 2009, physicians used point of care rapid immunoassay tests to provide influenza results within 15 minutes…
HHS awarded a $487 million contract to Novartis to build a facility to manufacture cell-based influenza vaccine
On Jan. 15, 2009, the U.S. Dept. of Health and Human Services (HHS) awarded Novartis a $487 million…
Drs. Judith James and Linda Thompson at the OMRF helped develop a H1N1 or ‘swine flu’ vaccine
In 2009, Drs. Judith James and Linda Thompson at the Oklahoma Medical Research Foundation (OMRF) helped develop an…
Australia approved locally made bird flu vaccine
On Jun. 15, 2008, Australia announced it had approved the first locally made vaccine to protect humans from…
ACIP voted to expand influenza recommendation to include vaccination for children ages 6 months-18 years
On Feb. 27, 2008, the Immunization Practices Advisory Committee (Immunization Practices Advisory Committee (ACIP) voted to expand influenza…
The CDC received FDA approval for a highly sensitive influenza PCR assay
In 2008, the U.S. Centers for Disease Control and Prevention (CDC) received U.S. Food and Drug Administration (FDA)…
CDC | Diagnostics | Influenza | Therapeutics
The Influenza Reagent Resource was established by the CDC
In 2008, the Influenza Reagent Resource (IRR) was established by the Centers for Disease Control and Prevention (CDC)…
Merck voluntarily recalled 12 million doses of Haemophilus influenzae type b
On Dec. 12, 2007, Merck voluntarily recalled 1.2 million doses of Haemophilus influenzae type b (Hib) vaccines due…
ACIP voted to recommend the use of FluMist
On Oct. 26, 2007, the Immunization Practices Advisory Committee (ACIP) voted to recommend the use of FluMist, the…
FDA approved Afluria, a new inactivated influenza vaccine for use in people age 18 years and older
On Sept. 28, 2007, the U.S. Food and Drug Administration (FDA) approved an Australian-made influenza vaccine called Afluria…
FDA approved use of FluMist nasal-spray influenza vaccine in children age 2-5 years
On Sept. 20, 2007, the U.S. Food and Drug Administration (FDA) approved use of FluMist nasal-spray influenza vaccine…
Nonpharmaceutical interventions implemented by U.S. cities during the 1918-1919 influenza pandemic
On Aug. 8, 2007, JAMA reported that research demonstrated a strong association between early, sustained, and layered application…
Biotechnology | CDC | Diagnostics | Infectious Disease | Influenza | NIH | Polio | Vaccine | WHO
U.S. CDC announced International Health Regulations had gone into effect for the U.S.
On Jul. 20, 2007, the U.S. Centers for Disease Control and Prevention (CDC) announced in MMWR that revised…
HHS announced $175 million to assist states in pandemic influenza preparedness efforts
On Jul. 17, 2007, The U.S. Department of Health and Human Services (HHS) announced it was providing states,…
HHS awarded $132.5 million to Sanofi Pasteur and MedImmune over five years to retrofit existing domestic vaccine manufacturing facilities
On Jun. 14, 2007, the U.D. of Health and Human Services (HHS) awarded $132.5 million to Sanofi Pasteur…
Biotechnology | COVID-19 | Diagnostics | Disease | Influenza | Plague | Therapeutics | Vaccine
Fort Knox prepared for pandemic outbreak scenarios
On Jun. 7, 2007, years before the COVID-19 pandemic swept across the globe, a group of about 100…
FDA approved the H5N1 vaccine, the first vaccine approved for avian flu
On Apr. 17, 2007, Sanofi announced that the U.S. Food and Drug Administration (FDA) had licensed its H5N1…
CDC published Interim Pre-pandemic Planning Guidance Strategy for Pandemic Influenza Mitigation in the U.S.
On Feb. 1, 2007, the Centers for Disease Control and Prevention (CDC) released its long-awaited disease containment strategy…
FDA licensed the refrigerator formulation of FluMist
On Jan. 9, 2007, the U.S. Food and Drug Administration (FDA) announced it had approved a refrigerated form…
Biotechnology | CDC | Influenza | Therapeutics | Vaccine
Human infection with a novel influenza virus was added to the nationally notifiable disease list
On Jan. 9, 2007, the Executive Committee of the Council of State and Territorial Epidemiologists approved an interim…
Sanofi Pasteur delivered H5N1 vaccine for U.S. government pandemic initiatives
On Feb. 6, 2006, Sanofi pasteur announced it had delivered more H5N1 vaccine to the U.S. government including…
Biotechnology | CDC | Diagnostics | Influenza | Vaccine
CDC stopped recommending adamantanes during 2005 season after high levels of influenza A (H3N2) virus resistance
On Jan. 17, 2006, the Centers for Disease Control and Prevention (CDC) announced that it had stopped recommending…
Federal Medicare rule required all long-term care facilities to offer vaccination for influenza and pneumococcal disease
On Oct. 7, 2005, a new Federal Medicare rule became effective that required all long-term care facilities to…
The genome of the 1918 H1N1 pandemic influenza virus was sequenced
On Oct. 7, 2005, Jeffery Taubenberger, AH Reid, AE Krafft, Karen Bijwaard and Thomas Fanning published a report…
An inactivated, injectable influenza vaccine was licensed
On Aug. 31, 2005, the inactivated, injectable influenza vaccine (Fluarix) by GlaxoSmithKline (GSK) was licensed. The vaccine was…
HHS awarded a contract for $97 million to Sanofi Pasteur to develop cell culture-based influenza vaccines for the U.S.
On Apr. 1, 2005, Sanofi pasteur was awarded a five-year $97 million contract from the U.S. Department of…